“ADJUVANT XELOX CHEMOTHERAPY OUTCOMES IN HIGH-RISK STAGE II AND STAGE III COLON CANCER: EVIDENCE FROM THAI BINH GENERAL HOSPITAL” (2026) Vietnam Journal of Community Medicine, 67(10). doi:10.52163/yhc.v67i10.6908.